Literature DB >> 30846495

The transcriptomic profile of CD138+ cells from patients with early progression from smoldering to active multiple myeloma remains substantially unchanged.

Paola Storti1,2, Luca Agnelli3,4, Benedetta Dalla Palma5,6, Katia Todoerti3,4, Valentina Marchica5,2, Fabrizio Accardi5,6, Gabriella Sammarelli6, Federica Deluca5, Denise Toscani5, Federica Costa5, Emanuela Vicario5, Giannalisa Todaro5, Eugenia Martella7, Antonino Neri3,4, Nicola Giuliani8,2,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30846495      PMCID： PMC6886434          DOI： 10.3324/haematol.2018.209999

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  19 in total

1.  The molecular classification of multiple myeloma.

Authors:  Fenghuang Zhan; Yongsheng Huang; Simona Colla; James P Stewart; Ichiro Hanamura; Sushil Gupta; Joshua Epstein; Shmuel Yaccoby; Jeffrey Sawyer; Bart Burington; Elias Anaissie; Klaus Hollmig; Mauricio Pineda-Roman; Guido Tricot; Frits van Rhee; Ronald Walker; Maurizio Zangari; John Crowley; Bart Barlogie; John D Shaughnessy
Journal:  Blood       Date:  2006-05-25       Impact factor: 22.113

2.  Bone marrow stromal cells create a permissive microenvironment for myeloma development: a new stromal role for Wnt inhibitor Dkk1.

Authors:  Jessica A Fowler; Gregory R Mundy; Seint T Lwin; Claire M Edwards
Journal:  Cancer Res       Date:  2012-02-28       Impact factor: 12.701

3.  Long noncoding RNA signatures define oncogenic subtypes in T-cell acute lymphoblastic leukemia.

Authors:  A Wallaert; K Durinck; W Van Loocke; I Van de Walle; F Matthijssens; P J Volders; F Avila Cobos; D Rombaut; P Rondou; P Mestdagh; J Vandesompele; B Poppe; T Taghon; J Soulier; P Van Vlierberghe; F Speleman
Journal:  Leukemia       Date:  2016-04-22       Impact factor: 11.528

4.  Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myeloma.

Authors:  Benedetta Dalla Palma; Valentina Marchica; Mario Pedrazzoni; Fabrizio Accardi; Laura Notarfranchi; Matteo Goldoni; Federica De Luca; Federica Costa; Paola Storti; Denise Toscani; Gabriella Sammarelli; Sabrina Bonomini; Franco Aversa; Nicola Giuliani
Journal:  Br J Haematol       Date:  2017-11-16       Impact factor: 6.998

Review 5.  Long non coding RNA XIST as a prognostic cancer marker - A meta-analysis.

Authors:  Qun Zhou; Wei Hu; Wei Zhu; Feng Zhang; Li Lin-Lin; Cong Liu; Yi-Yan Songyang; Cheng-Cao Sun; Dejia Li
Journal:  Clin Chim Acta       Date:  2018-03-23       Impact factor: 3.786

Review 6.  Evolutionary biology of high-risk multiple myeloma.

Authors:  Charlotte Pawlyn; Gareth J Morgan
Journal:  Nat Rev Cancer       Date:  2017-08-24       Impact factor: 60.716

Review 7.  International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

Authors:  S Vincent Rajkumar; Meletios A Dimopoulos; Antonio Palumbo; Joan Blade; Giampaolo Merlini; María-Victoria Mateos; Shaji Kumar; Jens Hillengass; Efstathios Kastritis; Paul Richardson; Ola Landgren; Bruno Paiva; Angela Dispenzieri; Brendan Weiss; Xavier LeLeu; Sonja Zweegman; Sagar Lonial; Laura Rosinol; Elena Zamagni; Sundar Jagannath; Orhan Sezer; Sigurdur Y Kristinsson; Jo Caers; Saad Z Usmani; Juan José Lahuerta; Hans Erik Johnsen; Meral Beksac; Michele Cavo; Hartmut Goldschmidt; Evangelos Terpos; Robert A Kyle; Kenneth C Anderson; Brian G M Durie; Jesus F San Miguel
Journal:  Lancet Oncol       Date:  2014-10-26       Impact factor: 41.316

8.  Clinical, genomic, and imaging predictors of myeloma progression from asymptomatic monoclonal gammopathies (SWOG S0120).

Authors:  Madhav V Dhodapkar; Rachael Sexton; Sarah Waheed; Saad Usmani; Xenofon Papanikolaou; Bijay Nair; Nathan Petty; John D Shaughnessy; Antje Hoering; John Crowley; Robert Z Orlowski; Bart Barlogie
Journal:  Blood       Date:  2013-10-21       Impact factor: 22.113

9.  The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma.

Authors:  Erming Tian; Fenghuang Zhan; Ronald Walker; Erik Rasmussen; Yupo Ma; Bart Barlogie; John D Shaughnessy
Journal:  N Engl J Med       Date:  2003-12-25       Impact factor: 91.245

10.  Pathway-based network analysis of myeloma tumors: monoclonal gammopathy of unknown significance, smoldering multiple myeloma, and multiple myeloma.

Authors:  L Dong; C Y Chen; B Ning; D L Xu; J H Gao; L L Wang; S Y Yan; S Cheng
Journal:  Genet Mol Res       Date:  2015-08-14
View more
  4 in total

Review 1.  Recent updates on CAR T clinical trials for multiple myeloma.

Authors:  Quande Lin; Juanjuan Zhao; Yongping Song; Delong Liu
Journal:  Mol Cancer       Date:  2019-11-05       Impact factor: 27.401

2.  Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine Availability.

Authors:  Martina Chiu; Denise Toscani; Valentina Marchica; Giuseppe Taurino; Federica Costa; Massimiliano G Bianchi; Roberta Andreoli; Valentina Franceschi; Paola Storti; Jessica Burroughs-Garcia; Rosa Alba Eufemiese; Benedetta Dalla Palma; Nicoletta Campanini; Eugenia Martella; Cristina Mancini; Jixiu Shan; Michael S Kilberg; Giovanna D'Amico; Erica Dander; Luca Agnelli; Giancarlo Pruneri; Gaetano Donofrio; Ovidio Bussolati; Nicola Giuliani
Journal:  Cancers (Basel)       Date:  2020-11-05       Impact factor: 6.639

3.  Longitudinal single-cell analysis of a myeloma mouse model identifies subclonal molecular programs associated with progression.

Authors:  Laura M Richards; Serges P Tsofack; Danielle C Croucher; Daniel Waller; Zhihua Li; Ellen Nong Wei; Xian Fang Huang; Marta Chesi; P Leif Bergsagel; Michael Sebag; Trevor J Pugh; Suzanne Trudel
Journal:  Nat Commun       Date:  2021-11-03       Impact factor: 17.694

4.  Deciphering spatial genomic heterogeneity at a single cell resolution in multiple myeloma.

Authors:  Maximilian Merz; Almuth Maria Anni Merz; Jie Wang; Lei Wei; Qiang Hu; Nicholas Hutson; Cherie Rondeau; Kimberly Celotto; Ahmed Belal; Ronald Alberico; AnneMarie W Block; Hemn Mohammadpour; Paul K Wallace; Joseph Tario; Jesse Luce; Sean T Glenn; Prashant Singh; Megan M Herr; Theresa Hahn; Mehmet Samur; Nikhil Munshi; Song Liu; Philip L McCarthy; Jens Hillengass
Journal:  Nat Commun       Date:  2022-02-10       Impact factor: 17.694
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.